VIR Vir Biotechnology, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$11,17
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$4,8252 haftanın en düşüğü
$11,9452 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.89B
P/E (TTM)
-6.0
Hisse Başına Kâr (TTM)
$-1.86
Gelir (TTM)
$303M
rozetleriniz
52 Haftlık Aralık
$5–$12
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$21
P/E
-6.0
ROE
-26.1%
Net Kâr Marjı
-83.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
VIR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$11.17
Piyasa Değeri (MRQ)
$1.89B
P/E (TTM)
-6.0
Hisse Başına Kâr (TTM)
$-1.86
Gelir (TTM)
$303M
ROE (TTM)
-26.1%
52 Haftlık Aralık
$5–$12
VIR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Vir Biotechnology, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar367
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$69M2017-12-31 → 2025-12-31
Hisse Başına Kâr$-3.162019-12-31 → 2025-12-31
Serbest Nakit Akışı$-397M2019-12-31 → 2025-12-31
Net kar marjı-83.0%2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | VIR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -6.05Y ort. ≈2.2 | ≈2.2 | · | · | |
| F/S (TTM) | 6.25Y ort. ≈9.7 | ≈9.7 | 7.4 | Düşük değerli | |
| F/D (MRQ) | 1.95Y ort. ≈1.7 | ≈1.7 | 3.8 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -9.35Y ort. ≈-16.6 | ≈-16.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -9.35Y ort. ≈-23.9 | ≈-23.9 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 1.95Y ort. ≈1.7 | ≈1.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | VIR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -92.4%5Y ort. ≈-438.9% | ≈-438.9% | -171.9% | En üst düzey | |
| FAVÖK Marjı (TTM) | -88.6%5Y ort. ≈-427.0% | ≈-427.0% | -171.9% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -82.9%5Y ort. ≈-395.1% | ≈-395.1% | -91.1% | En üst düzey | |
| Net Kâr Marjı (TTM) | -83.0%5Y ort. ≈-395.2% | ≈-395.2% | -159.6% | En üst düzey | |
| ROA (TTM) | -20.9%5Y ort. ≈-7.1% | ≈-7.1% | -32.2% | Aynı seviyede | |
| ROE (TTM) | -26.1%5Y ort. ≈-12.5% | ≈-12.5% | -58.3% | En üst düzey | |
| ROIC | -62.7%5Y ort. ≈-20.0% | ≈-20.0% | -62.7% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | VIR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 6.05Y ort. ≈6.6 | ≈6.6 | 6.3 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 5.05Y ort. ≈5.9 | ≈5.9 | 5.1 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | VIR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -7.6%5Y ort. ≈253.1% | ≈253.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -65.1%5Y ort. ≈-40.1% | ≈-40.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -2.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | VIR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.15Y ort. ≈0.3 | ≈0.3 | 0.1 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$186.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-125.6%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 4, 2026 | $0.47 | $0.34 | 39.8% |
| 31 Mart 2026 | $-0.85 | $-0.10 | -781.7% | |
| 31 Aralık 2025 | $-0.31 | $-0.50 | 37.6% | |
| 30 Eylül 2025 | $-1.17 | $-0.86 | -35.7% | |
| 30 Haziran 2025 | $-0.80 | $-0.73 | -9.5% | |
| 31 Mart 2025 | $-0.88 | $-0.84 | -4.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | $11M | |
| Cost of Revenue | $26.0K | $845.0K | $3M | $146M | $66M | $0 | $0 | · | |
| R&D Expense | $456M | $506M | $580M | $475M | $448M | $302M | $148M | $100M | |
| SG&A Expense | $92M | $119M | $174M | $162M | $161M | $71M | $38M | $29M | |
| Operating Expenses | $548M | $661M | $770M | $783M | $675M | $373M | $186M | $129M | |
| Operating Income | $-479M | $-587M | $-684M | $833M | $421M | $-297M | $-178M | $-119M | |
| Interest Income | $40M | $72M | $87M | $28M | · | · | $9M | $3M | |
| Other Non-op | $-409.0K | $-2M | $-9M | $4M | $-9M | $-4M | $-5M | $-212.0K | |
| Pretax Income | $-438M | $-523M | $-628M | $754M | $550M | $-299M | $-175M | $-116M | |
| Income Tax | $217.0K | $-1M | $-13M | $238M | $21M | $54.0K | $154.0K | $-480.0K | |
| Net Income | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | $-116M | |
| EPS (Basic) | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | · | |
| EPS (Diluted) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · | |
| Shares (Basic) | 138,520,419 | 136,246,865 | 134,130,924 | 132,606,767 | 129,884,967 | 119,159,424 | 30,349,920 | · | |
| Shares (Diluted) | 138,520,419 | 136,246,865 | 134,130,924 | 134,810,908 | 133,437,126 | 119,159,424 | 30,349,920 | · | |
| EBITDA | $-468M | $-573M | $-665M | $839M | $426M | $-293M | $-175M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $232M | $223M | $242M | $849M | $348M | $437M | $109M | $48M | |
| Short-term Investments | $229M | $678M | $1.27B | $1.52B | $217M | $300M | $274M | $51M | |
| Receivables | · | · | · | $0 | $773M | $0 | · | · | |
| Prepaid Expense | $45M | $48M | $53M | $104M | $73M | $28M | $13M | $9M | |
| Other Current Assets | · | $100.0K | $8M | $26M | · | · | · | · | |
| Current Assets | $514M | $1.04B | $1.59B | $2.52B | $1.56B | $772M | $403M | $118M | |
| PP&E (Net) | $56M | $63M | $96M | $106M | $43M | $18M | $16M | $12M | |
| PP&E (Gross) | $103M | $100M | $130M | $126M | $57M | $27M | $21M | $14M | |
| Accum. Depreciation | $47M | $37M | $34M | $21M | $14M | $9M | $5M | $2M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $8M | $8M | $23M | $33M | $33M | $34M | $36M | $37M | |
| Total Assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Accounts Payable | $10M | $5M | $6M | $6M | $7M | $5M | $6M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | $26M | $15M | |
| Current Liabilities | $93M | $120M | $175M | $511M | $341M | $99M | $59M | $40M | |
| Capital Leases | $89M | $90M | $112M | $124M | $134M | $67M | · | · | |
| Deferred Tax | · | · | · | $3M | $18M | $3M | $3M | · | |
| Other Non-current Liabilities | $22M | $15M | $16M | $11M | $3M | $4M | $4M | $2M | |
| Total Liabilities | $238M | $248M | $329M | $724M | $522M | $202M | $88M | $62M | |
| Common Stock | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $11.0K | $1.0K | |
| Paid-in Capital | $1.97B | $1.91B | $1.83B | $1.71B | $1.57B | $1.39B | $793M | $15M | |
| Retained Earnings | $-1.20B | $-760M | $-238M | $377M | $-139M | $-667M | $-369M | $-194M | |
| AOCI | $-2M | $-2M | $-815.0K | $-9M | $-1M | $-1M | $-601.0K | $-14.0K | |
| Stockholders' Equity | $765M | $1.15B | $1.59B | $2.08B | $1.43B | $717M | $424M | $-179M | |
| Liabilities + Equity | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Shares Outstanding | 139,474,954 | 136,959,446 | 134,781,286 | 133,236,687 | 131,161,404 | 127,416,740 | 107,648,925 | 8,858,799 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $15M | $19M | $7M | $5M | $4M | $3M | $2M | |
| Stock-based Comp | $49M | $78M | $111M | $102M | $84M | $28M | $9M | $5M | |
| Deferred Tax | $304.0K | $-3M | $-1M | $-15M | $15M | $-52.0K | · | $-500.0K | |
| Amort. of Intangibles | · | · | $531.0K | $532.0K | $533.0K | $1M | $1M | $1M | |
| Restructuring | · | $35M | $14M | · | · | · | · | · | |
| Other Non-cash | $-15M | $-14M | $-293M | $1.05B | $-680M | $76M | $33M | · | |
| Operating Cash Flow | $-392M | $-446M | $-779M | $1.66B | $-48M | $-191M | $-130M | $-94M | |
| CapEx | $5M | $7M | $22M | $68M | $22M | $7M | $9M | $8M | |
| Investing Cash Flow | $310M | $499M | $165M | $-1.19B | $-141M | $-10M | $-256M | $-60M | |
| Stock Issued | · | · | · | $0 | $0 | $323M | $126M | · | |
| Net Stock Activity | · | · | · | $0 | · | $323M | $126M | · | |
| Financing Cash Flow | $4M | $4M | $7M | $35M | $100M | $529M | $449M | $25M | |
| Net Change in Cash | $-78M | $57M | $-607M | $505M | $-88M | $329M | $63M | $-130M | |
| Taxes Paid | $2M | $786.0K | $3M | $-252M | $0 | $0 | · | · | |
| Free Cash Flow | $-397M | $-454M | $-800M | $1.60B | $-69M | $-197M | $-139M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% | -388.9% | -2199.7% | · | |
| Net Margin | -638.9% | -703.4% | -713.8% | 31.9% | 48.2% | -391.1% | -2159.0% | · | |
| Pretax Margin | -638.6% | -705.0% | -728.9% | 46.7% | 50.2% | -391.0% | -2157.1% | · | |
| EBITDA Margin | -682.1% | -771.6% | -772.1% | 51.9% | 38.9% | -383.1% | -2159.0% | · | |
| ROA | -36.5% | -31.5% | -26.1% | 21.7% | 36.8% | -41.8% | -49.6% | · | |
| ROE | -51.1% | -43.7% | -37.7% | 24.4% | 45.8% | -39.1% | -244.1% | · | |
| ROIC | -62.7% | -50.9% | -42.1% | 27.4% | 28.2% | -41.4% | -42.0% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 | 7.8 | 6.8 | · | |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 | 7.4 | 6.5 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.7 | 0.8 | 0.1 | 0.0 | · | |
| Receivables Turnover | · | · | · | 4.2 | 2.8 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.49 | $8.40 | $11.80 | $15.60 | $10.92 | $5.63 | $3.94 | · | |
| Revenue / Share | $0.49 | $0.54 | $0.64 | $11.99 | $8.21 | · | · | · | |
| Cash Flow / Share | $-2.83 | $-3.28 | $-5.81 | $12.34 | $-0.36 | · | · | · | |
| Cash / Share | $1.66 | $1.63 | $1.79 | $6.37 | $2.65 | $3.43 | $1.02 | · | |
| EPS (TTM) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.6% | -13.9% | -94.7% | 47.5% | 1334.4% | · | · | · | |
| Revenue CAGR 3Y | -65.1% | -59.2% | 4.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -3.3% | · | · | · | · | |
| Net Income YoY | · | · | · | -2.4% | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | · | |
| Net Income TTM | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | · | |
| Market Cap | $841M | $1.01B | $1.36B | $3.37B | $5.49B | $3.41B | $1.35B | · | |
| P/E | -1.9 | -1.9 | -2.2 | 6.6 | 10.6 | -10.7 | -2.2 | · | |
| P/S | 12.3 | 13.5 | 15.7 | 2.1 | 5.0 | 44.7 | 167.3 | · | |
| P/B | 1.1 | 0.9 | 0.9 | 1.6 | 3.8 | 4.8 | 3.2 | · | |
| P / Tangible Book | 1.1 | 0.9 | 0.9 | 1.7 | 4.0 | 5.1 | · | · | |
| P / Cash Flow | -2.1 | -2.3 | -1.7 | 2.0 | -115.4 | -17.9 | -10.4 | · | |
| P / FCF | -2.1 | -2.2 | -1.7 | 2.1 | -79.1 | -17.3 | -9.8 | · | |
| Earnings Yield | -52.4% | -52.2% | -45.6% | 15.1% | 9.5% | -9.4% | -45.8% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239M | $-29.0K | $64M | $240.0K | $1M | $3M | $12M | $2M | $3M | $56M | $17M | $3M | $4M | $63M | $49M | $375M | |
| Cost of Revenue | $0 | · | · | · | $11.0K | $0 | $684.0K | $50.0K | $52.0K | $59.0K | $798.0K | $38.0K | $22.0K | $2M | $6M | $22M | |
| R&D Expense | $135M | $109M | $88M | $151M | $98M | $119M | $106M | $195M | $105M | $100M | $109M | $145M | $168M | $158M | $155M | $114M | |
| SG&A Expense | $30M | $23M | $24M | $22M | $22M | $24M | $27M | $26M | $30M | $36M | $41M | $41M | $46M | $47M | $39M | $43M | |
| Operating Expenses | $165M | $132M | $112M | $174M | $120M | $143M | $130M | $234M | $162M | $136M | $156M | $189M | $219M | $206M | $200M | $180M | |
| Operating Income | $73M | $-132M | $-48M | $-173M | $-118M | $-140M | $-117M | $-231M | $-159M | $-80M | $-139M | $-187M | $-215M | $-143M | $-151M | $195M | |
| Interest Income | $9M | $7M | $8M | $9M | $11M | $12M | $14M | $18M | $19M | $21M | $21M | $22M | · | · | · | · | |
| Other Non-op | $-451.0K | $-254.0K | $-335.0K | $-228.0K | $226.0K | $-72.0K | $-506.0K | $-893.0K | $-535.0K | $-287.0K | $-1M | $882.0K | $-367.0K | $-8M | $-26M | $27M | |
| Pretax Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-140M | $-65M | $-121M | $-167M | $-198M | $-143M | $-152M | $218M | |
| Income Tax | $179.0K | $170.0K | $-137.0K | $168.0K | $170.0K | $16.0K | $-86.0K | $177.0K | $-2M | $276.0K | $-5M | $-3M | $-3M | $-2M | $-50M | $42M | |
| Net Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-138M | $-65M | $-116M | $-163M | $-195M | $-141M | $-102M | $175M | |
| EPS (Basic) | $0.48 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.78 | $1.32 | |
| EPS (Diluted) | $0.47 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.74 | $1.30 | |
| Shares (Basic) | 167,719,015 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 132,729,530 | |
| Shares (Diluted) | 168,879,127 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 134,963,317 | |
| EBITDA | $73M | $-129M | · | $-173M | $-118M | $-137M | · | $-231M | $-159M | $-76M | · | $-182M | $-211M | $-138M | · | $197M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $279M | $274M | $232M | $170M | $211M | $274M | $223M | $168M | $297M | $161M | $242M | $452M | $667M | $825M | $849M | $964M | |
| Short-term Investments | $250M | $196M | $229M | $328M | $388M | $517M | $678M | $741M | $850M | $985M | · | $1.23B | $1.17B | $1.41B | · | $1.36B | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $39M | $45M | $45M | $37M | $41M | $42M | $48M | $43M | $41M | $50M | · | $59M | $86M | $98M | · | $54M | |
| Other Current Assets | · | · | · | · | · | · | · | $0 | $1M | $4M | · | $5M | $13M | $18M | · | · | |
| Current Assets | $574M | $523M | $514M | $546M | $736M | $932M | $1.04B | $1.05B | $1.21B | $1.21B | · | $1.77B | $1.95B | $2.36B | · | $2.41B | |
| PP&E (Net) | $50M | $53M | $56M | $58M | $61M | $62M | $63M | $65M | $66M | $92M | · | $99M | $104M | $104M | · | $100M | |
| PP&E (Gross) | $103M | $103M | $103M | $103M | $102M | $101M | $100M | $100M | $99M | $131M | · | $129M | $130M | $130M | · | $119M | |
| Accum. Depreciation | $53M | $50M | $47M | $44M | $42M | $39M | $37M | $35M | $33M | $38M | · | $30M | $26M | $26M | · | $19M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $19M | $19M | $22M | · | $25M | $26M | $33M | · | $33M | |
| Total Assets | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Accounts Payable | $18M | $5M | $10M | $7M | $12M | $4M | $5M | $7M | $4M | $7M | · | $4M | $12M | $12M | · | $3M | |
| Current Liabilities | $95M | $74M | $93M | $75M | $105M | $137M | $120M | $117M | $96M | $94M | · | $165M | $226M | $485M | · | $308M | |
| Capital Leases | $84M | $87M | $89M | $91M | $93M | $88M | $90M | $93M | $95M | $109M | · | $114M | $118M | $121M | · | $127M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | $18M | |
| Other Non-current Liabilities | $19M | $19M | $22M | $13M | $13M | $15M | $15M | $14M | $14M | $14M | · | $13M | $12M | $8M | · | $7M | |
| Total Liabilities | $232M | $213M | $238M | $223M | $245M | $264M | $248M | $258M | $236M | $247M | · | $370M | $434M | $695M | · | $546M | |
| Common Stock | $17.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Paid-in Capital | $2.23B | $2.14B | $1.97B | $1.95B | $1.94B | $1.93B | $1.91B | $1.89B | $1.88B | $1.85B | · | $1.80B | $1.77B | $1.74B | · | $1.68B | |
| Retained Earnings | $-1.24B | $-1.32B | $-1.20B | $-1.15B | $-992M | $-881M | $-760M | $-655M | $-441M | $-303M | · | $-122M | $42M | $236M | · | $479M | |
| AOCI | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $1M | $-3M | $-2M | · | $-2M | $-3M | $-3M | · | $-12M | |
| Stockholders' Equity | $982M | $813M | $765M | $796M | $947M | $1.04B | $1.15B | $1.24B | $1.43B | $1.55B | $1.59B | $1.68B | $1.81B | $1.97B | $2.08B | $2.15B | |
| Liabilities + Equity | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Shares Outstanding | 169,185,671 | 161,234,058 | 139,474,954 | 139,022,594 | 138,886,274 | 138,063,698 | 136,959,446 | 136,706,350 | 136,590,097 | 135,843,560 | 134,781,286 | 134,497,886 | 134,230,494 | 133,930,957 | 133,236,687 | 133,027,358 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $4M | $5M | $6M | $2M | $2M | |
| Stock-based Comp | $12M | $12M | $11M | $11M | $12M | $14M | $16M | $17M | $22M | $24M | $28M | $27M | $31M | $25M | $25M | $25M | |
| Deferred Tax | · | · | · | · | · | · | $-3M | $57.0K | · | · | $-1M | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $133.0K | $133.0K | $133.0K | · | $133.0K | |
| Restructuring | · | · | · | · | · | · | $-4M | $13M | $26M | $-48.0K | · | · | · | · | · | · | |
| Other Non-cash | · | $-22M | · | · | · | $26M | · | · | · | $-72M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $123M | $-132M | $-26M | $-168M | $-120M | $-78M | $-88M | $-171M | $-78M | $-109M | $-108M | $-156M | $-389M | $-126M | $35M | $118M | |
| CapEx | $32.0K | $390.0K | $348.0K | $317.0K | $3M | $2M | $2M | $3M | $666.0K | $2M | $2M | $4M | $9M | $7M | $13M | $19M | |
| Investing Cash Flow | $-197M | $12M | $87M | $40M | $56M | $127M | $141M | $119M | $212M | $28M | $-105M | $-59M | $230M | $98M | $-153M | $-663M | |
| Stock Issued | · | $162M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $162M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $78M | $163M | $1M | $102.0K | $2M | $598.0K | $1M | $31.0K | $3M | $152.0K | $2M | $277.0K | $3M | $2M | $2M | $2M | |
| Net Change in Cash | $5M | $42M | $62M | $-127M | $-62M | $49M | $54M | $-53M | $137M | $-81M | $-211M | $-215M | $-156M | $-25M | $-116M | $-543M | |
| Taxes Paid | · | · | $154.0K | $5M | · | · | · | $0 | · | · | · | · | · | · | $-444M | $102M | |
| Free Cash Flow | · | $-133M | · | · | · | $-80M | · | · | · | $-111M | · | · | · | $-133M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.8% | 456172.4% | · | -72267.9% | -9754.3% | -4602.5% | · | -9718.7% | -5158.7% | -142.1% | · | -7075.9% | -5667.3% | -227.7% | · | 52.0% | |
| Net Margin | 33.5% | 433431.0% | · | -67975.4% | -9139.9% | -3989.6% | · | -8979.7% | -4500.1% | -115.8% | · | -6192.2% | -5129.7% | -223.9% | · | 46.8% | |
| Pretax Margin | 33.6% | 432844.8% | · | -67905.4% | -9125.9% | -3989.1% | · | -8972.3% | -4549.3% | -115.3% | · | -6314.0% | -5204.7% | -227.4% | · | 58.1% | |
| EBITDA Margin | 30.8% | 446479.3% | · | -72267.9% | -9754.3% | -4507.9% | · | -9718.7% | -5158.7% | -134.0% | · | -6905.3% | -5546.1% | -219.0% | · | 52.5% | |
| ROA | 6.7% | -10.8% | · | -13.0% | -7.8% | -7.8% | · | -12.1% | -7.1% | -2.9% | · | -6.9% | -8.0% | -5.1% | · | 9.0% | |
| ROE | 8.3% | -13.5% | · | -16.0% | -9.3% | -9.3% | · | -14.7% | -8.5% | -3.7% | · | -8.5% | -10.3% | -7.1% | · | 11.6% | |
| ROIC | 7.5% | -16.3% | · | -21.8% | -12.5% | -13.4% | · | -18.7% | -10.9% | -5.2% | · | -10.9% | -11.7% | -7.2% | · | 7.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 7.1 | · | 7.3 | 7.0 | 6.8 | · | 8.9 | 12.5 | 12.9 | · | 10.7 | 8.6 | 4.9 | · | 7.8 | |
| Quick Ratio | 5.6 | 6.4 | · | 6.6 | 5.7 | 5.8 | · | 7.8 | 11.9 | 12.2 | · | 10.2 | 8.1 | 4.6 | · | 7.5 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.1 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.81 | $5.04 | · | $5.73 | $6.82 | $7.56 | · | $9.08 | $10.50 | $11.39 | · | $12.45 | $13.49 | $14.71 | · | $16.16 | |
| Revenue / Share | $1.41 | $-0.00 | · | $0.00 | $0.01 | $0.02 | · | $0.02 | $0.02 | $0.42 | · | $0.02 | $0.03 | $0.47 | · | $2.78 | |
| Cash Flow / Share | · | $-0.90 | · | · | · | $-0.57 | · | · | · | $-0.81 | · | · | · | $-0.94 | · | · | |
| Cash / Share | $1.65 | $1.70 | · | $1.22 | $1.52 | $1.98 | · | $1.23 | $2.17 | $1.18 | · | $3.36 | $4.97 | $6.16 | · | $7.24 | |
| EPS (TTM) | $-1.86 | $-3.13 | · | $-3.62 | $-4.01 | $-4.23 | · | $-3.92 | $-3.58 | $-4.01 | · | $-4.47 | $-1.95 | $-1.08 | · | $8.57 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $303M | $65M | · | $17M | $19M | $21M | · | $79M | $79M | $80M | · | $119M | $491M | $446M | · | $2.38B | |
| Net Income TTM | $-252M | $-443M | · | $-500M | $-550M | $-578M | · | $-533M | $-483M | $-539M | · | $-601M | $-262M | $-144M | · | $1.14B | |
| Market Cap | $1.72B | $1.44B | · | $794M | $700M | $895M | · | $1.02B | $1.22B | $1.38B | · | $1.26B | $3.29B | $3.12B | · | $2.56B | |
| P/E | -5.5 | -2.9 | · | -1.6 | -1.3 | -1.5 | · | -1.9 | -2.5 | -2.5 | · | -2.1 | -12.6 | -21.5 | · | 2.2 | |
| P/S | 5.7 | 22.1 | · | 47.1 | 36.8 | 42.9 | · | 13.0 | 15.4 | 17.3 | · | 10.6 | 6.7 | 7.0 | · | 1.1 | |
| P/B | 1.8 | 1.8 | · | 1.0 | 0.7 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 0.8 | 1.8 | 1.6 | · | 1.2 | |
| P / Tangible Book | 1.8 | 1.8 | · | 1.0 | 0.8 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.9 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -10.9 | · | · | · | -11.5 | · | · | · | -12.6 | · | · | · | -24.8 | · | · | |
| Earnings Yield | -18.2% | -34.9% | · | -63.4% | -79.6% | -65.3% | · | -52.3% | -40.2% | -39.6% | · | -47.7% | -8.0% | -4.6% | · | 44.5% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $69M | $74M | $86M | $1.62B | $1.10B |
| Faaliyet Kâr Marjı % | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% |
| Net Gelir | $-438M | $-522M | $-615M | $516M | $529M |
| Seyreltilmiş Hisse Başı Kâr | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 |
| Cari Oran | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-397M | $-454M | $-800M | $1.60B | $-69M |
Kurumsal Sahipler (13F) 255 dosya · $1.6B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
255
Tutulan Değer
$1.6B
Yeni pozisyonlar
34
Çıkan pozisyonlar
43
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 34 (-42 önceki Ç'ye göre) | 43 (+16 önceki Ç'ye göre) | 95 (-25 önceki Ç'ye göre) | 76 (+35 önceki Ç'ye göre) | +7.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $210.711.705 | 20.678.283 | 13,43% | Hisse senetleri |
| ARCH Venture Management, LLC | $129.353.521 | 12.694.163 | 8,25% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.136.241 | 11.495.215 | 7,47% | Hisse senetleri |
| SB INVESTMENT ADVISERS (UK) LTD | $111.561.068 | 10.948.093 | 7,11% | Hisse senetleri |
| STATE STREET CORP | $101.534.699 | 9.964.151 | 6,47% | Hisse senetleri |
| GSK plc | $87.134.221 | 8.550.954 | 5,55% | Hisse senetleri |
| VANGUARD GROUP INC | $75.670.133 | 12.548.944 | 4,82% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $65.101.617 | 6.388.775 | 4,15% | Hisse senetleri |
| Point72 Asset Management, L.P. | $57.744.906 | 5.666.821 | 3,68% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $34.124.708 | 3.348.366 | 2,18% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $31.789.627 | 3.119.421 | 2,03% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $25.033.539 | 2.456.677 | 1,60% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $24.101.581 | 2.365.219 | 1,54% | Hisse senetleri |
| FMR LLC | $23.623.417 | 2.318.294 | 1,51% | Hisse senetleri |
| MORGAN STANLEY | $22.530.881 | 2.211.077 | 1,44% | Hisse senetleri |
| Nuveen, LLC | $20.206.180 | 1.982.942 | 1,29% | Hisse senetleri |
| Pictet Asset Management Holding SA | $19.904.290 | 1.953.316 | 1,27% | Hisse senetleri |
| Boxer Capital Management, LLC | $19.014.540 | 1.866.000 | 1,21% | Hisse senetleri |
| NORTHERN TRUST CORP | $14.593.762 | 1.432.165 | 0,93% | Hisse senetleri |
| Hudson Bay Capital Management LP | $13.899.160 | 1.364.000 | 0,89% | Hisse senetleri |
| GordonMD Global Investments LP | $13.792.695 | 1.353.552 | 0,88% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.483.255 | 1.323.185 | 0,86% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $11.642.473 | 1.142.539 | 0,74% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $11.313.213 | 1.110.227 | 0,72% | Hisse senetleri |
| Sio Capital Management, LLC | $10.957.042 | 1.075.274 | 0,70% | Hisse senetleri |
| Savvy Advisors, Inc. | $10.604.376 | 1.040.665 | 0,68% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $10.361.844 | 1.016.864 | 0,66% | Hisse senetleri |
| Soleus Capital Management, L.P. | $10.190.000 | 1.000.000 | 0,65% | Hisse senetleri |
| CITADEL ADVISORS LLC | $10.101.724 | 991.337 | 0,64% | Hisse senetleri |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8.699.050 | 853.685 | 0,55% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $8.575.466 | 841.557 | 0,55% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $8.496.208 | 833.779 | 0,54% | Hisse senetleri |
| JPMORGAN CHASE & CO | $8.330.957 | 802.597 | 0,53% | Hisse senetleri |
| ALGERT GLOBAL LLC | $8.202.716 | 804.977 | 0,52% | Hisse senetleri |
| Saturn V Capital Management LP | $7.852.852 | 770.643 | 0,50% | Hisse senetleri |
| Bank of New York Mellon Corp | $7.075.671 | 694.374 | 0,45% | Hisse senetleri |
| Jones Hill Capital LP | $6.717.380 | 659.213 | 0,43% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $6.661.121 | 653.692 | 0,42% | Hisse senetleri |
| Qube Research & Technologies Ltd | $6.536.742 | 641.486 | 0,42% | Hisse senetleri |
| Candriam S.C.A. | $6.379.827 | 626.690 | 0,41% | Hisse senetleri |
| Clearstead Advisors, LLC | $6.197.906 | 608.234 | 0,40% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $6.098.079 | 593.776 | 0,39% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $5.980.490 | 586.898 | 0,38% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $5.924.626 | 581.416 | 0,38% | Hisse senetleri |
| Weiss Asset Management LP | $5.660.963 | 555.541 | 0,36% | Hisse senetleri |
| Avidity Partners Management LP | $5.291.667 | 519.300 | 0,34% | Hisse senetleri |
| Walleye Capital LLC | $5.240.218 | 514.251 | 0,33% | Hisse senetleri |
| Alta Partners Management Company, L.P. | $5.196.054 | 509.917 | 0,33% | Hisse senetleri |
| Invesco Ltd. | $4.845.804 | 475.545 | 0,31% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $4.843.093 | 475.279 | 0,31% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee ×8 başvurular | 03 Mart 2026 | 8,50% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 31 içeriden öğrenenler · 13 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Marianne De Backer | President and CEO | 29 Nisan 2026 J | 286.650 | 0 | 3 | $-947.163 |
| Jason O'Byrne | EVP & Chief Financial Officer | 20 Mart 2026 J | 2.500 | 0 | 3 | $-68.937 |
| Sung Lee | EVP & Chief Financial Officer | 27 Mart 2024 S | 100.492 | 0 | 0 | $0 |
| Howard Horn | CFO | 23 Şubat 2023 S | 230.712 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | EVP & Chief Operating Officer | 03 Mart 2023 S | 148.518 | 0 | 0 | $0 |
| Brent Sabatini | SVP, Chief Accounting Officer | 01 Haziran 2026 S | 61.902 | 0 | 5 | $-113.079 |
| Vanina De Verneuil | EVP, General Counsel, Corp Sec | 25 Şubat 2026 S | 112.982 | 0 | 5 | $-217.660 |
| Mark Eisner | EVP and Chief Medical Officer | 25 Şubat 2026 S | 154.024 | 0 | 3 | $-49.513 |
| Ann M. Hanly | EVP & Chief Technology Officer | 24 Şubat 2025 S | 117.901 | 0 | 0 | $0 |
| Phillip Pang | EVP & Chief Medical Officer | 22 Şubat 2024 S | 250.111 | 0 | 0 | $0 |
| Steven J. Rice | Chief Administrative Officer | 01 Haziran 2023 S | 106.840 | 0 | 0 | $0 |
| Herbert Virgin | EVP, Research & CSO | 09 Ağustos 2022 M | 262.500 | 0 | 0 | $0 |
| Jay Parrish | Chief Business Officer | 01 Nisan 2021 M | 9.260 | 0 | 0 | $0 |
| Robert J More | Yönetim kurulu üyesi | 11 Ağustos 2026 J | 517.917 | 0 | 0 | $0 |
| Timothy Coughlin | Yönetim kurulu üyesi | 09 Haziran 2026 A | 16.000 | 0 | 0 | $0 |
| Janet Napolitano | Yönetim kurulu üyesi | 01 Haziran 2026 S | 21.216 | 0 | 1 | $-30.240 |
| Ramy Farid | Yönetim kurulu üyesi | 27 Mayıs 2026 A | 32.000 | 0 | 0 | $0 |
| Charles Elliott Sigal | Yönetim kurulu üyesi | 27 Mayıs 2026 A | 39.806 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Yönetim kurulu üyesi | 27 Mayıs 2026 A | 39.806 | 0 | 0 | $0 |
| Norbert W Bischofberger | Yönetim kurulu üyesi | 27 Mayıs 2026 A | 21.333 | 0 | 0 | $0 |
| Vicki L Sato | Yönetim kurulu üyesi | 01 Mayıs 2026 S | 1.078.391 | 0 | 10 | $-1.599.174 |
| Saira Ramasastry | Yönetim kurulu üyesi | 30 Mayıs 2025 A | 22.619 | 0 | 0 | $0 |
| George A Scangos | Yönetim kurulu üyesi | 24 Şubat 2025 S | 698.239 | 0 | 0 | $0 |
| Robert Nelsen | Yönetim kurulu üyesi | 30 Mayıs 2024 A | 584.148 | 0 | 0 | $0 |
| Robert J Perez | Yönetim kurulu üyesi | 22 Mayıs 2023 A | 15.806 | 0 | 0 | $0 |
| SHARP PHILLIP A | Yönetim kurulu üyesi | 22 Mayıs 2023 A | 121.174 | 0 | 0 | $0 |
| Dipchand Nishar | Yönetim kurulu üyesi | 21 Mayıs 2021 A | 3.374 | 0 | 0 | $0 |
| Kristina Burow | Yönetim kurulu üyesi | 21 Mayıs 2020 A | 1.000.000 | 0 | 0 | $0 |
| Klaus Frueh | Yönetim kurulu üyesi | 16 Ekim 2019 C | 362.844 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10% sahip | 16 Ekim 2019 C | 2.777.777 | 0 | 0 | $0 |
| Alaska Permanent Fund Corp | 10% sahip | 16 Ekim 2019 C | 5.555.556 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 47 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,37% | 330.932 SH | 11 Eylül 2026 | Günlük |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,77% | 122.287 SH | 01 Ekim 2026 | Günlük |
| BBC · ETFis Series Trust I | 0,67% | 36.099 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,29% | 168.048 NS | 31 Temmuz 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,21% | 48.466 SH | 01 Ekim 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 12.019 SH | 01 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,10% | 1.021.218 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 221.169 SH | 01 Ekim 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,09% | 18.546 SH | 01 Ekim 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,08% | 2.296 NS | 31 Temmuz 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,08% | 152.022 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 106.919 SH | 19 Ağustos 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,07% | 423.304 SH | 19 Ağustos 2026 | Günlük |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,06% | 59.262 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,04% | 3.144.068 SH | 11 Eylül 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 2.019.005 SH | 19 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 79.032 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 707.200 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 58.849 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 535.641 NS | 31 Temmuz 2026 | N-PORT |
| TECB · iShares Trust | 0,03% | 13.104 SH | 11 Eylül 2026 | Günlük |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 35.521 SH | 01 Ekim 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.484.960 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 352.449 SH | 19 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,02% | 15.668 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 55.806 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 9.191 SH | 11 Eylül 2026 | Günlük |
| SMDX · Tidal Trust III | 0,01% | 1.987 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.398.053 SH | 19 Ağustos 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,01% | 4.496 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 372.749 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 22.418 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 10.879 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 9.821 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 39.437 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 41.614 SH | 10 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 173.654 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 45.317 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.846.948 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.300 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 7.406.345 SH | 10 Eylül 2026 | Günlük |
| IJT · iShares Trust | · | 472.791 SH | 09 Eylül 2026 | Günlük |
| IJS · iShares Trust | · | 635.538 SH | 08 Eylül 2026 | Günlük |
| IWN · iShares Trust | · | 1.143.981 SH | 11 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 16.840 SH | 31 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 5.053 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 13.735 SH | 11 Eylül 2026 | Günlük |
VIR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$20.00
+79,1%
4 28,6%
Güçlü Al
9 64,3%
Al
1 7,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
9 analist · 2026-09-28Ortalama hedef $20.78 +86,0%
← Tüm hedeflerin altında
Mevcut fiyat $11.17
Düşük$15.00
Ortalama$20.78
Yüksek$30.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
Son Haberler Bu şirketten bahseden son manşetler
Vir'da %99'luk Hissedar Rallisi Ortasında Yeni Bir 6 Milyon Dolarlık Pozisyon Açan Biyoteknoloji Fonu Neden Vir'a Yatırım Yaptı?
Nasdaq · 4 ay, 1 hafta önce
Vir Biotechnology Yönetim Kurulu Başkanı 22.000 Şirket Hissesi Sattı. Bunun Yatırımcılar İçin Anlamı Bu.
Nasdaq · 4 ay, 3 hafta önce
Vir Biotechnology, Inc. (VIR) Şimdi Alınacak İyi Bir Hisse Senedi mi?
Yahoo Finance · 5 ay önce
Vir Biotechnology (VIR) CEO 664.000 Dolar Karşılığında 73.000 Hissederek Satıyor
Nasdaq · 5 ay, 3 hafta önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026